Equities Analysts Offer Predictions for Nukkleus Q2 Earnings

Nukkleus Inc. (NASDAQ:DFNS) – Investment analysts at Zacks Research issued their Q2 2026 earnings per share (EPS) estimates for Nukkleus in a research report issued on Wednesday, June 24th. Zacks Research analyst T. Kerr anticipates that the company will post earnings per share of ($0.05) for the quarter. Zacks Research also issued estimates for Nukkleus’ Q3 2026 earnings at ($0.04) EPS, Q4 2026 earnings at ($0.03) EPS, FY2026 earnings at ($0.99) EPS, FY2027 earnings at ($0.04) EPS, FY2028 earnings at $0.01 EPS, FY2029 earnings at $0.03 EPS and FY2030 earnings at $0.06 EPS.

A number of other research firms have also weighed in on DFNS. Weiss Ratings reissued a “sell (d+)” rating on shares of Nukkleus in a research report on Thursday, June 18th. Wall Street Zen cut Nukkleus from a “hold” rating to a “sell” rating in a report on Saturday, April 18th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock presently has a consensus rating of “Sell”.

Nukkleus Price Performance

Nukkleus stock opened at $0.18 on Friday. Nukkleus has a 12-month low of $0.16 and a 12-month high of $15.59. The stock has a market capitalization of $10.73 million, a P/E ratio of -0.06 and a beta of -6.00. The firm’s 50-day moving average is $0.39 and its two-hundred day moving average is $1.81. The company has a debt-to-equity ratio of 0.07, a current ratio of 0.25 and a quick ratio of 0.21.

Nukkleus (NASDAQ:DFNS) last posted its quarterly earnings data on Wednesday, May 20th. The company reported ($1.14) EPS for the quarter. The company had revenue of $3.65 million during the quarter.

Institutional Investors Weigh In On Nukkleus

Several hedge funds have recently modified their holdings of the stock. BNP Paribas Financial Markets purchased a new stake in Nukkleus in the second quarter valued at approximately $56,000. UBS Group AG boosted its holdings in shares of Nukkleus by 23.3% in the 3rd quarter. UBS Group AG now owns 80,512 shares of the company’s stock valued at $564,000 after purchasing an additional 15,223 shares during the last quarter. Ausdal Financial Partners Inc. purchased a new stake in shares of Nukkleus during the 3rd quarter valued at $105,000. Geode Capital Management LLC grew its stake in shares of Nukkleus by 193.7% during the 4th quarter. Geode Capital Management LLC now owns 124,714 shares of the company’s stock valued at $503,000 after buying an additional 82,252 shares during the period. Finally, LPL Financial LLC acquired a new stake in shares of Nukkleus during the 4th quarter worth $120,000. 12.47% of the stock is owned by institutional investors and hedge funds.

More Nukkleus News

Here are the key news stories impacting Nukkleus this week:

• Positive Sentiment: Nukkleus recently announced that its defense-focused business, T3 Defense, will present at the Maxim Group Defense Tech and Domestic Supply Chain Virtual Conference, which can help raise investor visibility and interest in the stock. Article Title
• Neutral Sentiment: Zacks Research issued a set of earnings estimates for Nukkleus across fiscal 2026 through 2030, including a projected FY2026 loss of $0.99 per share followed by a gradual path toward small profits later in the forecast period. The estimates give investors a new benchmark, but they do not appear to be a major positive or negative surprise on their own.
• Negative Sentiment: Short interest jumped sharply in June to 12.7 million shares, with about 27.1% of the float sold short. That signals significant bearish sentiment and highlights elevated skepticism around the stock’s outlook. Article Title

About Nukkleus

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.